 |
|||||||
|
|
Andrew Hollings Andrew Hollings is a Co-Founder of Novarum. He is based in New York. Prior to the establishment of Novarum in 2008, Andrew Hollings held the position of Managing Director in Citigroup Global Markets Inc. and President of Citigroup Counterparty Risk LLC. Mr. Hollings joined Citigroup in 2002 to establish a global Counterparty Credit Risk management function. Prior to joining Citigroup Global Markets, Mr. Hollings held the position of Managing Director and Global Head of the New Financial Products Group at JPMorgan Chase. His responsibilities included actively managing the counterparty credit risk for the global OTC derivatives business. Mr. Hollings established the New Financial Products Group in Chase Manhattan Bank, prior to its merger with JPMorgan. In this role he was responsible for managing a team that traded a portfolio of complex hybrid risk products. He has previously held various positions in the Fixed Income business of Chemical Bank and Manufacturers Hanover Trust in London, Tokyo and New York. Mr. Hollings has 20 years of experience in the derivatives industry. Andrew Hollings received a BSc (Hon) in Economics & Finance and an MA in Economics from the University of Wales, College of Cardiff. |
© 2008 Novarum Partners Limited